BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16262900)

  • 1. Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.
    Pullamsetti S; Krick S; Yilmaz H; Ghofrani HA; Schudt C; Weissmann N; Fuchs B; Seeger W; Grimminger F; Schermuly RT
    Respir Res; 2005 Nov; 6(1):128. PubMed ID: 16262900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
    McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
    Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
    Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
    Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension.
    Schermuly RT; Yilmaz H; Ghofrani HA; Woyda K; Pullamsetti S; Schulz A; Gessler T; Dumitrascu R; Weissmann N; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 2005 Aug; 172(3):358-63. PubMed ID: 15879421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension.
    Merklinger SL; Jones PL; Martinez EC; Rabinovitch M
    Circulation; 2005 Jul; 112(3):423-31. PubMed ID: 16027270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
    Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN
    Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
    Altiere RJ; Olson JW; Gillespie MN
    J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
    Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Schudt C; Tenor H; Grimminger F; Seeger W; Walmrath D
    J Pharmacol Exp Ther; 2000 Feb; 292(2):512-20. PubMed ID: 10640287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline.
    Qin Y; Zhou A; Ben X; Shen J; Liang Y; Li F
    Chin Med J (Engl); 2001 May; 114(5):462-5. PubMed ID: 11780404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertension.
    Kato S; Sugimura H; Kishiro I; Machida M; Suzuki H; Kaneko N
    Exp Lung Res; 2002 Jun; 28(4):265-73. PubMed ID: 12042029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor.
    Cowan KN; Heilbut A; Humpl T; Lam C; Ito S; Rabinovitch M
    Nat Med; 2000 Jun; 6(6):698-702. PubMed ID: 10835689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D; Reid LM
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.
    Mitani Y; Maruyama K; Sakurai M
    Circulation; 1997 Jul; 96(2):689-97. PubMed ID: 9244244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats.
    Ono M; Sawa Y; Mizuno S; Fukushima N; Ichikawa H; Bessho K; Nakamura T; Matsuda H
    Circulation; 2004 Nov; 110(18):2896-902. PubMed ID: 15505094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Sudoh K; Sasamata M; Miyata K
    Eur J Pharmacol; 2004 Aug; 496(1-3):129-39. PubMed ID: 15288584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic unloading leads to regression of pulmonary vascular disease in rats.
    O'Blenes SB; Fischer S; McIntyre B; Keshavjee S; Rabinovitch M
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):279-89. PubMed ID: 11174733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
    Schermuly RT; Ghofrani HA; Enke B; Weissmann N; Grimminger F; Seeger W; Schudt C; Walmrath D
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.